ACCL vs SURG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 14, 2026
ACCL
SURG
Investment Advisor Scores
SURG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ACCL | SURG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 15.1515 | Tie |
| PEG Ratio | 0 | 0.5333 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.0% | 40.7% | SURG |
| Earnings Growth | -84.0% | -77.7% | SURG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 63.1/100 | 45.2/100 | ACCL |
| Profit Margin | 11.3% | -47.9% | ACCL |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ACCL
MarkupPrice above SMA50, rising 50-day trend (8.8% over 20 days), RSI 58
SURG
MarkdownPrice below a falling SMA50 (slope -22.7%), weak momentum, RSI 35
Fundamentals Snapshot
| Metric | ACCL | SURG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 12.7 |
| Trailing P/E | 67.3 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.4% |
| Gross Margin | 0.4% | -0.2% |
| Operating Margin | 0.0% | 0.2% |
| EPS | 0.04 | -1.50 |
| Dividend Yield | — | — |